|
C9ORF82 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.962300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.397500E-04 |
| Normal-vs-Stage2 |
4.284400E-02 |
| Normal-vs-Stage3 |
4.394500E-04 |
| Normal-vs-Stage4 |
7.471700E-02 |
| Stage1-vs-Stage2 |
4.302000E-01 |
| Stage1-vs-Stage3 |
4.674800E-01 |
| Stage1-vs-Stage4 |
7.005000E-01 |
| Stage2-vs-Stage3 |
2.011000E-01 |
| Stage2-vs-Stage4 |
8.573200E-01 |
| Stage3-vs-Stage4 |
4.134400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.816500E-04 |
| Normal-vs-AfricanAmerican |
4.924700E-03 |
| Normal-vs-Asian |
6.583900E-02 |
| Caucasian-vs-AfricanAmerican |
6.443200E-01 |
| Caucasian-vs-Asian |
8.909400E-01 |
| AfricanAmerican-vs-Asian |
7.723800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.757500E-04 |
| Normal-vs-Female |
7.609000E-04 |
| Male-vs-Female |
5.223600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.044920E-03 |
| Normal-vs-Extreme_Weight |
1.059920E-03 |
| Normal-vs-Obese |
4.598800E-03 |
| Normal-vs-Extreme_Obese |
2.324400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.359200E-01 |
| Normal_Weight-vs-Obese |
6.704400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.865000E-01 |
| Extreme_Weight-vs-Obese |
7.863200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.393600E-01 |
| Obese-vs-Extreme_Obese |
5.547000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.225540E-02 |
| Normal-vs-Age(41-60Yrs) |
2.563500E-03 |
| Normal-vs-Age(61-80Yrs) |
8.032800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.036150E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.854600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.246600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.835600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.199600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.395620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.631400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.399800E-03 |
| Normal-VS-Type2 PRCC |
3.81170000000042E-05 |
| Normal-VS-KIRP CIMP |
6.416300E-02 |
| Normal-VS-Unclassified PRCC |
4.622800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.583000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.952000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.883600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.691200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.239600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.291200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.84380000000695E-05 |
| Normal-vs-N1 |
2.47469999999916E-05 |
| Normal-vs-N2 |
6.917100E-03 |
| N0-vs-N1 |
3.345000E-01 |
| N0-vs-N2 |
2.343800E-01 |
| N1-vs-N2 |
3.919400E-01 |
|
|
